A genome-wide search for common SNP x SNP interactions on the risk of venous thrombosis

BackgroundVenous Thrombosis (VT) is a common multifactorial disease with an estimated heritability between 35% and 60%. Known genetic polymorphisms identified so far only explain ~5% of the genetic variance of the disease. This study was aimed to investigate whether pair-wise interactions between common single nucleotide polymorphisms (SNPs) could exist and modulate the risk of VT.MethodsA genome-wide SNP x SNP interaction analysis on VT risk was conducted in a French case–control study and the most significant findings were tested for replication in a second independent French case–control sample. The results obtained in the two studies totaling 1,953 cases and 2,338 healthy subjects were combined into a meta-analysis.ResultsThe smallest observed p-value for interaction was p = 6.00 10-11 but it did not pass the Bonferroni significance threshold of 1.69 10-12 correcting for the number of investigated interactions that was 2.96 1010. Among the 37 suggestive pair-wise interactions with p-value less than 10-8, one was further shown to involve two SNPs, rs9804128 (IGFS21 locus) and rs4784379 (IRX3 locus) that demonstrated significant interactive effects (p = 4.83 10-5) on the variability of plasma Factor VIII levels, a quantitative biomarker of VT risk, in a sample of 1,091 VT patients.ConclusionThis study, the first genome-wide SNP interaction analysis conducted so far on VT risk, suggests that common SNPs are unlikely exerting strong interactive effects on the risk of disease.

[1]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[2]  F. Rosendaal.  Venous thrombosis: a multicausal disease , 1999, The Lancet.

[3]  L. Almasy,et al.  Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. , 2000, American journal of human genetics.

[4]  W. Gauderman.  Sample size requirements for association studies of gene-gene interaction. , 2002, American journal of epidemiology.

[5]  R. Holman,et al.  Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population , 2003, Neuroepidemiology.

[6]  Alain Favier,et al.  The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. , 2004, Archives of internal medicine.

[7]  D. A. Tregouet,et al.  A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies , 2007, Bioinform..

[8]  Markus Perola,et al.  Combined Effects of Thrombosis Pathway Gene Variants Predict Cardiovascular Events , 2007, PLoS genetics.

[9]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[10]  Eugene Demidenko,et al.  Sample size and optimal design for logistic regression with binary interaction , 2008, Statistics in medicine.

[11]  Andrew D. Johnson,et al.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..

[12]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[13]  P. Reitsma,et al.  Polymorphisms in the protein C gene as risk factor for venous thrombosis , 2008, Thrombosis and Haemostasis.

[14]  S. Heath,et al.  Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. , 2009, Blood.

[15]  H. Cordell.  Detecting gene–gene interactions that underlie human diseases , 2009, Nature Reviews Genetics.

[16]  Benjamin J. Wright,et al.  Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease , 2009, Nature Genetics.

[17]  Jason H. Moore,et al.  Missing heritability and strategies for finding the underlying causes of complex disease , 2010, Nature Reviews Genetics.

[18]  D. Tregouet,et al.  Deciphering the molecular basis of venous thromboembolism: where are we and where should we go? , 2010, British journal of haematology.

[19]  D. Tregouet,et al.  Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels , 2011, BMC Medical Genetics.

[20]  F. Cambien,et al.  Genetics of Venous Thrombosis: Insights from a New Genome Wide Association Study , 2011, PloS one.

[21]  D. Tregouet,et al.  Lessons from genome‐wide association studies in venous thrombosis , 2011, Journal of thrombosis and haemostasis : JTH.

[22]  Yoav Ben-Shlomo,et al.  Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease. , 2012, American journal of human genetics.

[23]  Carolyn Hutter,et al.  Powerful Cocktail Methods for Detecting Genome‐Wide Gene‐Environment Interaction , 2012, Genetic epidemiology.

[24]  D. Chasman,et al.  Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta‐analysis of eight studies , 2012, Journal of thrombosis and haemostasis : JTH.

[25]  Attila Gyenesei,et al.  High-throughput analysis of epistasis in genome-wide association studies with BiForce , 2012, Bioinform..

[26]  Masao Ueki,et al.  Improved Statistics for Genome-Wide Interaction Analysis , 2012, PLoS genetics.

[27]  D. Trégouët,et al.  Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project , 2012, British journal of haematology.

[28]  Kristel Van Steen,et al.  Travelling the world of gene-gene interactions , 2012, Briefings Bioinform..